Who founded Pylum Biosciences?

Pylum Biosciences was founded by David W. Martin, James L. Knighton, Jeffery F. Miller in 2016.

How much funding has Pylum Biosciences raised?

Pylum Biosciences has disclosed $990K raised across 1 round.

Where is Pylum Biosciences headquartered?

Pylum Biosciences is headquartered in South San Francisco, US.

Pylum Biosciences

South San Francisco, US · Founded 2016 · Delaware corporation

Find your way into Pylum Biosciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Pylum Biosciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Pylum Bio is a biotechnology company developing therapeutics, drawing on microbiology, immunology, and molecular genetics research. Its leadership includes founders and directors with backgrounds in pharmaceutical R&D and life sciences.

Biotech Deep Tech Healthtech

Founders & leadership

Pylum Biosciences was founded in 2016 by David W. Martin, James L. Knighton, and Jeffery F. Miller.

David W. MartinCo-founder

James L. KnightonCo-founder

Jeffery F. MillerCo-founder

Stephen CreagerNamed on SEC filing

Kevin CameronNamed on SEC filing

Jeffrey MillerNamed on SEC filing

Miguel BarbosaNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$990K disclosed across 1 round · 2020

▶$990KraisedMar 2020 · 29 investors · Biotechnology

Rule 506(c)

Officers, directors & promoters on the filing

James KnightonExecutive Officer, Director
Stephen CreagerExecutive Officer
David MartinDirector
Kevin CameronDirector
Jeffrey MillerDirector
Miguel BarbosaDirector

Offering amount: $1M
Amount sold: $990K
First sale: Feb 2020
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 7

Pillar BiosciencesPillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.

LumenLumen develops orally delivered antibody drugs using engineered spirulina, a patented biologic platform that reduces manufacturing costs and timelines compared to conventional biologics. The company serves biopharma customers seeking alternatives to traditional drug manufacturing.

Talus BioTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.

Mirum PharmaceuticalsMirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases. It operates in the U.S. and Europe, engaging with healthcare professionals, patients, and payers within applicable regulatory frameworks.

Epirium BioEpirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy. The company's lead compound, EPM-01, is in Phase 1 clinical development for Becker muscular dystrophy.

Precision BioSciencesPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

TATUM BioscienceTATUM bioscience develops biotech solutions, though the page provides limited detail on specific products or target markets.

Companies working in the same space as Pylum Biosciences.

Frequently asked questions

What does Pylum Biosciences do?: Pylum Bio is a biotechnology company developing therapeutics, drawing on microbiology, immunology, and molecular genetics research. Its leadership includes founders and directors with backgrounds in pharmaceutical R&D and life sciences.
Who founded Pylum Biosciences?: Pylum Biosciences was founded by David W. Martin, James L. Knighton, Jeffery F. Miller in 2016.
How much funding has Pylum Biosciences raised?: Pylum Biosciences has disclosed $990K raised across 1 round.
Where is Pylum Biosciences headquartered?: Pylum Biosciences is headquartered in South San Francisco, US.